• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Uptake Medical launches registry study for InterVapor lung device

Uptake Medical launches registry study for InterVapor lung device

January 14, 2016 By Fink Densford

Uptake Medical

Uptake Medical said today it launched a registry trial of its InterVapor system to investigate long-term clinical results in severe emphysema patients.

The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said.

“Until InterVapor, severe emphysema was typically treated either by requiring patients to undergo highly invasive open surgical lobectomy, or applying foreign material into their lungs. InterVapor offers a less-invasive, bronchoscopic approach that allows clinicians to limit treatment only to the discrete portions of a patient’s lung that have been targeted,” CEO King Nelson said in a press release.

Patients enrolled in the registry trial will be asked to return for follow-up visits to assess lung function and quality of life, the Tustin, Calif.-based company said.

“The progressive nature of emphysema dictates that we perform ongoing patient monitoring and intervention. InterVapor allows us to take a segmental approach to lung volume reduction, which is advantageous because we can perform subsequent procedures when warranted. It gives these patients therapeutic options not available in any other treatment modality,” Dr. Prof. Felix Herth of Heidelberg, Germany’s Thoraxklinik said in prepared remarks.

The company said 6-month data from its Step-Up randomized clinical trial indicated that patients experienced statistically significant improvements in both lung function and quality of life, as well.

In October, Uptake Medical said it’s InterVapor targeted vapor therapy system was used in the 1st-ever regional lung cancer tumor ablation procedure.

The patient treated with the system was diagnosed with colorectal cancer that metastasized to the lung. The procedure was performed by Dr. Arschang Valipour at Vienna’s Otto-Wagner-Spital Hospital, Tustin, Calif.-based Uptake said.

Filed Under: Clinical Trials, Oncology, Respiratory Tagged With: uptakemedical

More recent news

  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy